168 related articles for article (PubMed ID: 30007661)
21. Re-visiting the structure of heparin.
Casu B; Naggi A; Torri G
Carbohydr Res; 2015 Feb; 403():60-8. PubMed ID: 25088334
[TBL] [Abstract][Full Text] [Related]
22. Authentication of animal origin of heparin and low molecular weight heparin including ovine, porcine and bovine species using 1D NMR spectroscopy and chemometric tools.
Monakhova YB; Diehl BWK; Fareed J
J Pharm Biomed Anal; 2018 Feb; 149():114-119. PubMed ID: 29112899
[TBL] [Abstract][Full Text] [Related]
23. Qualitative and quantitative analysis of 2, 5-anhydro-d-mannitol in low molecular weight heparins with high performance anion exchange chromatography hyphenated quadrupole time of flight mass spectrometry.
Yi L; Zhang Q; Meng Y; Hao J; Xie B; Gan H; Li D; Dong K; Zhang Z
J Chromatogr A; 2018 Sep; 1569():160-167. PubMed ID: 30055911
[TBL] [Abstract][Full Text] [Related]
24. Quantitative PCR and disaccharide profiling to characterize the animal origin of low-molecular-weight heparins.
Houiste C; Auguste C; Macrez C; Dereux S; Derouet A; Anger P
Clin Appl Thromb Hemost; 2009 Feb; 15(1):50-8. PubMed ID: 18805847
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.
Ajayi AA; Pharmacols FB; Cooper J; Horn EH; Rubin PC
Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):539-45. PubMed ID: 18040530
[TBL] [Abstract][Full Text] [Related]
26. Differentiating low-molecular-weight heparins based on chemical, biological, and pharmacologic properties: implications for the development of generic versions of low-molecular-weight heparins.
Jeske WP; Walenga JM; Hoppensteadt DA; Vandenberg C; Brubaker A; Adiguzel C; Bakhos M; Fareed J
Semin Thromb Hemost; 2008 Feb; 34(1):74-85. PubMed ID: 18393144
[TBL] [Abstract][Full Text] [Related]
27. Bovine and porcine heparins: different drugs with similar effects on human haemodialysis.
Tovar AM; Teixeira LA; Rembold SM; Leite M; Lugon JR; Mourão PA
BMC Res Notes; 2013 Jun; 6():230. PubMed ID: 23763719
[TBL] [Abstract][Full Text] [Related]
28. A sensitive ELISA for the detection of bovine crude heparin in porcine heparin.
Levieux A; Rivera V; Levieux D
J Immunoassay Immunochem; 2001; 22(4):323-36. PubMed ID: 11816801
[TBL] [Abstract][Full Text] [Related]
29. Movement of heparins across rat gastric mucosa is dependent on molecular weight and pH.
Moazed B; Hiebert LM
Pharm Res; 2009 Jan; 26(1):189-95. PubMed ID: 18937058
[TBL] [Abstract][Full Text] [Related]
30. Generic low-molecular-weight heparins: some practical considerations.
Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
[TBL] [Abstract][Full Text] [Related]
31. Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin.
Viskov C; Bouley E; Hubert P; Martinez C; Herman F; Jeske W; Hoppensteadt D; Walenga JM; Fareed J
Clin Appl Thromb Hemost; 2009; 15(4):395-401. PubMed ID: 19617248
[TBL] [Abstract][Full Text] [Related]
32. Preparation of Low Molecular Weight Heparin from a Remodeled Bovine Intestinal Heparin.
Baytas SN; Varghese SS; Jin W; Yu Y; He P; Douaisi M; Zhang F; Brodfuehrer P; Xia K; Dordick JS; Linhardt RJ
J Med Chem; 2021 Feb; 64(4):2242-2253. PubMed ID: 33586962
[TBL] [Abstract][Full Text] [Related]
33. Structural and functional analyses of bovine and porcine intestinal heparins confirm they are different drugs.
Santos GRC; Tovar AMF; Capillé NVM; Pereira MS; Pomin VH; Mourão PAS
Drug Discov Today; 2014 Nov; 19(11):1801-1807. PubMed ID: 25019497
[TBL] [Abstract][Full Text] [Related]
34. Pharmacologic profile of a low-molecular-weight heparin depolymerized by gamma-irradiation.
Jeske W; Iqbal O; Gonnela S; Boveri G; Torri G; De Ambrosi L; Fareed J
Semin Thromb Hemost; 1995; 21(2):201-11. PubMed ID: 7660143
[TBL] [Abstract][Full Text] [Related]
35. Controllable production of low molecular weight heparins by combinations of heparinase I/II/III.
Wu J; Zhang C; Mei X; Li Y; Xing XH
Carbohydr Polym; 2014 Jan; 101():484-92. PubMed ID: 24299802
[TBL] [Abstract][Full Text] [Related]
36. Sequencing the oligosaccharide pool in the low molecular weight heparin dalteparin with offline HPLC and ESI-MS/MS.
Wang Z; Zhang T; Xie S; Liu X; Li H; Linhardt RJ; Chi L
Carbohydr Polym; 2018 Mar; 183():81-90. PubMed ID: 29352895
[TBL] [Abstract][Full Text] [Related]
37. Immunochemical control of the species origin of porcine crude heparin and detection of ovine and caprine materials.
Levieux A; Rivera V; Levieux D
J Pharm Biomed Anal; 2002 Jan; 27(1-2):305-13. PubMed ID: 11682238
[TBL] [Abstract][Full Text] [Related]
38. Feasibility study of heparin mass calibrator as a GPC calibrator for heparins and low molecular weight heparins.
Ahsan A; Jeske W; Mardiguian J; Fareed J
J Pharm Sci; 1994 Feb; 83(2):197-201. PubMed ID: 8169788
[TBL] [Abstract][Full Text] [Related]
39. Rapid molecular size characterization of heparins by high pressure liquid chromatography.
Sugisaka N; Petracek FJ
Fed Proc; 1977 Jan; 36(1):89-92. PubMed ID: 556606
[TBL] [Abstract][Full Text] [Related]
40. Structural features of low-molecular-weight heparins affecting their affinity to antithrombin.
Bisio A; Vecchietti D; Citterio L; Guerrini M; Raman R; Bertini S; Eisele G; Naggi A; Sasisekharan R; Torri G
Thromb Haemost; 2009 Nov; 102(5):865-73. PubMed ID: 19888521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
